cannogenin thevetoside
(PMTSPAGBAFCORP-HBUONDEYSA-N)
Structure
- SMILES
- CO[C@H]1[C@H](O)[C@H](O[C@H]2CC[C@]3([C@@H](C2)CC[C@@H]2[C@@H]3CC[C@]3([C@]2(O)CC[C@@H]3C2=CC(=O)OC2)C)C=O)O[C@H]([C@@H]1O)C
- Type(s)
- Experimental
- ATC code(s)
- C01AX02
- Molecular Formula:
- C30H44O9
- Molecular Weight:
- 548.665
- Log P:
- 2.2892
- Hydrogen Bond Acceptor:
- 9
- Hydrogen Bond Donor:
- 3
- TPSA:
- 131.75
- CAS Number(s):
- 1182-87-2
Synonym(s)
1.
cannogenin thevetoside
2.
3 beta,14 beta-dihydroxy-19-oxo-5 beta-card-20(22)-enolide-3 alpha-L-thevetoside
3.
encordin
4.
peruvoside
External Link(s)
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Myasthenia Gravis | 3036745 | CTD |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.